ADCT · Healthcare · $158M
$1.24+1.14%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
9/'26
6/'26 vs prev quarter
Among 326 Biotechnology peers
Quarterly Revenue Growth
“제품 매출은 1년 전 1,810만 달러에서 1,860만 달러로 소폭 늘었지만, 전체 매출 추이는 2,300만 달러에서 1,900만 달러로 세 분”
In the company's words · 2026 2분기 earnings call